Deaggregation Device for Emulsion PCR Sample Clumping

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Aggregated biological samples in emulsion PCR systems lead to issues such as clogging of fluidic lines, inhibited reaction with reagents, ineffective washing, and reduced accuracy in downstream analysis due to clumping, which results in loss of valuable samples and reduced throughput.

Innovation Solution

A deaggregation device, such as a valve manifold or channel, is used to process aggregated samples, optimizing dimensions and flow rates to declump samples before, during, or after nucleic acid amplification procedures, thereby preventing sample damage and ensuring efficient separation and analysis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If emulsion PCR amplification is performed on encapsulated nucleic acid samples, then large numbers of DNA copies can be generated simultaneously, but sample aggregation and clumping occur which cause clogging of fluidic lines and reduced throughput

Engineering Contradiction:
ImprovethroughputVSAvoidsample flow through fluidic lines
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The system performs preliminary deaggregation by passing the microsphere suspension through a valve manifold or channel before the amplification and analysis steps. This preliminary action breaks up aggregates and clumps formed during emulsion PCR, preventing clogging of fluidic lines and ensuring smooth flow through the system, thereby maintaining high throughput without sacrificing reliability

Inventive Principle:
Principle #10Preliminary action

2Device complexity

If aggregated samples are used in downstream analysis, then processing can be simplified, but reaction with reagents is inhibited and washing becomes ineffective leading to loss of valuable samples

Engineering Contradiction:
Improveprocessing stepsVSAvoidreaction efficiency and washing effectiveness
Core Design Contradiction:
Device complexityVSManufacturing precision

Solution Approach 1:

The valve manifold or channel performs a preliminary deaggregation step that disperses clustered microspheres into individual units before downstream processing. This ensures that each microsphere is accessible to reagents for effective hybridization and reaction, and allows washing steps to effectively reach and remove unbound materials from all surfaces, preventing loss of valuable samples while maintaining straightforward processing

Inventive Principle:
Principle #10Preliminary action

3Ease of operation

If samples are processed without deaggregation, then the system is simpler to operate, but clumping reduces accuracy in downstream analysis

Engineering Contradiction:
Improvesystem operation simplicityVSAvoiddownstream analysis accuracy
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The system incorporates a preliminary deaggregation step through the valve manifold or channel that automatically disperses aggregates before analysis. This maintains ease of operation as the deaggregation occurs automatically as part of the standard protocol, while simultaneously improving measurement precision by ensuring that individual microspheres are properly separated and accessible for accurate hybridization, washing, and detection in downstream analysis steps

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS8530158B2System and method for processing a biological sample
Publication Date: 2013.09.10 LIFE TECHNOLOGIES CORP
  • US8530158B2 patent drawing
  • US8530158B2 patent drawing
  • US8530158B2 patent drawing

AI summary

Systems and methods for processing a biological sample are provided herein. For example, the system can be configured to deaggregate/declump a sample before, during, and/or after sample preparation and/or sample analysis. For example, the system can include a deaggregation device/system in communication with, for example, a nucleic acid amplification process (e.g., an ePCR system). Various embodiments of the deaggregation device are provided herein. For example, in some embodiments, the deaggregation device can include a valve, a valve manifold, a conduit, a channel, or some combinations thereof.